# Chamomile Anxiety Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/chamomile-anxiety-randomized-trial-evidence-review
Category: evidence-review
Summary: Chamomile Anxiety Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixe
Last reviewed: 2026-06-16
Reviewed by: Migaku Evidence Review
# Chamomile Anxiety Randomized Trial: What the Evidence Says

## Quick Answer

Chamomile Anxiety Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Wild Flora Species from Romania with Anxiolytic and Antidepressant Potential: A Global Perspective—Narrative Review | preclinical study | 4 | 2026-04-30 | 10.3390/biomedicines14051019 |

## What The Sources Report

- However, despite this diversity, only a limited number of species have been sufficiently investigated and supported by pharmacological or clinical evidence regarding their anxiolytic and antidepressant effects. [Frenț Olimpia-Daniela (2026); evidence level 4]
- Although herbal preparations are often perceived as safer than synthetic drugs, the level of scientific evidence supporting their efficacy and safety remains variable. [Frenț Olimpia-Daniela (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For chamomile anxiety randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Frenț Olimpia-Daniela (2026). Wild Flora Species from Romania with Anxiolytic and Antidepressant Potential: A Global Perspective—Narrative Review. DOI: 10.3390/biomedicines14051019. PMCID: PMC13204971. PMID: 42193346. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13204971/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.